Xue Chen Selected Research

Body Piercing (Piercing, Body)

6/2019	Seroprevalence and risk factors on Syphilis among blood donors in Chengdu, China,from 2005 to 2017.
4/2011	Prevalence of and risk factors for hepatitis C virus infection among blood donors in Chengdu, China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xue Chen Research Topics

Disease

80	Neoplasms (Cancer) 07/2022 - 08/2002
27	Inflammation (Inflammations) 12/2022 - 01/2006
11	Insulin Resistance 01/2022 - 08/2008
11	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2003
11	Carcinogenesis 09/2021 - 03/2008
10	Infections 06/2022 - 05/2004
8	Type 2 Diabetes Mellitus (MODY) 06/2022 - 10/2010
8	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2017
8	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 04/2008
7	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 06/2010
7	Thrombosis (Thrombus) 05/2022 - 01/2006
7	Adenocarcinoma of Lung 01/2022 - 01/2013
7	Lymphoma (Lymphomas) 01/2022 - 01/2015
6	Wounds and Injuries (Trauma) 01/2023 - 01/2018
6	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 11/2015
6	Stomach Neoplasms (Stomach Cancer) 01/2022 - 02/2017
6	Atopic Dermatitis (Atopic Eczema) 06/2017 - 01/2011
5	Melanoma (Melanoma, Malignant) 01/2022 - 08/2002
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 03/2015
5	Diabetes Mellitus 01/2022 - 10/2017
5	Leukemia 04/2021 - 04/2014
4	Progeria (Hutchinson Gilford Syndrome) 10/2022 - 01/2020
4	Esophageal Neoplasms (Esophageal Cancer) 04/2022 - 12/2018
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2019
4	Breast Neoplasms (Breast Cancer) 10/2021 - 10/2017
4	Nasopharyngeal Carcinoma 09/2021 - 03/2008
4	Disease Progression 06/2021 - 01/2019
4	Esophageal Squamous Cell Carcinoma 01/2021 - 01/2020
4	Spinal Cord Injuries (Spinal Cord Injury) 01/2021 - 10/2011
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2016
4	Body Weight (Weight, Body) 01/2020 - 10/2016
4	Liver Neoplasms (Liver Cancer) 12/2018 - 06/2017
3	Atherosclerosis 12/2022 - 07/2016
3	Atherosclerotic Plaque (Atheroma) 12/2022 - 02/2009
3	Ovarian Neoplasms (Ovarian Cancer) 07/2022 - 01/2021
3	COVID-19 05/2022 - 01/2020
3	Ischemic Stroke 04/2022 - 09/2016
3	Hemorrhage 04/2022 - 01/2019
3	Hypertension (High Blood Pressure) 01/2022 - 04/2017
3	Metabolic Diseases (Metabolic Disease) 01/2022 - 02/2014
3	Pathologic Processes 01/2022 - 01/2019
3	Fatty Liver 01/2022 - 01/2020
3	Hyperuricemia 12/2020 - 01/2020

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 06/2022 - 04/2008
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2011
11	Pharmaceutical PreparationsIBA 01/2022 - 09/2002
11	Biological ProductsIBA 01/2022 - 09/2002
9	MicroRNAs (MicroRNA)IBA 01/2021 - 11/2011
8	Messenger RNA (mRNA)IBA 06/2021 - 04/2008
8	CytokinesIBA 01/2021 - 04/2008
8	Sirtuin 1IBA 10/2016 - 07/2011
7	LipidsIBA 06/2022 - 01/2018
7	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2015
7	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2018
7	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 03/2010
7	Therapeutic UsesIBA 01/2021 - 06/2019
7	Retinaldehyde (Retinal)IBA 01/2019 - 04/2015
6	AntioxidantsIBA 06/2022 - 11/2009
6	Circular RNAIBA 01/2022 - 10/2017
6	EnzymesIBA 01/2022 - 03/2016
6	LigandsIBA 01/2022 - 01/2011
6	LipopolysaccharidesIBA 12/2021 - 07/2012
6	Cisplatin (Platino)FDA LinkGeneric 09/2021 - 01/2018
6	Advanced Glycation End ProductsIBA 05/2015 - 11/2009
6	Oxidants (Oxidizing Agents)IBA 04/2014 - 11/2009
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2019
5	Indicators and Reagents (Reagents)IBA 01/2022 - 03/2004
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2006
5	CateninsIBA 01/2019 - 01/2015
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2022 - 01/2018
4	Peptides (Polypeptides)IBA 05/2022 - 01/2021
4	IntegrinsIBA 01/2022 - 01/2012
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 05/2004
4	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2020
4	Long Noncoding RNAIBA 01/2022 - 01/2019
4	CholesterolIBA 01/2022 - 07/2016
4	Neuroprotective AgentsIBA 12/2021 - 09/2016
4	Folic Acid (Vitamin M)FDA LinkGeneric 06/2021 - 01/2013
4	Melanins (Melanin)IBA 01/2021 - 03/2016
4	IronIBA 09/2020 - 03/2016
4	Interleukin-6 (Interleukin 6)IBA 08/2020 - 03/2016
3	Transcription Factors (Transcription Factor)IBA 07/2022 - 03/2008
3	Hormones (Hormone)IBA 07/2022 - 07/2018
3	VaccinesIBA 01/2022 - 01/2013
3	ChemokinesIBA 01/2022 - 04/2008
3	Fluorouracil (Carac)FDA LinkGeneric 09/2021 - 08/2020
3	CollagenIBA 02/2021 - 04/2019
3	Ethanol (Ethyl Alcohol)IBA 01/2021 - 01/2017
3	Nicotine FDA Link 01/2021 - 11/2018
3	Uric Acid (Urate)IBA 12/2020 - 01/2020
3	AcidsIBA 12/2020 - 01/2017
3	PotassiumIBA 08/2020 - 01/2017

Therapy/Procedure

30	Therapeutics 05/2022 - 05/2004
14	Radiotherapy 04/2022 - 07/2010
6	Drug Therapy (Chemotherapy) 01/2022 - 01/2018
6	Immunotherapy 01/2022 - 01/2018
5	Hematopoietic Stem Cell Transplantation 01/2022 - 03/2015
4	Stem Cell Transplantation 01/2023 - 01/2020
3	Lasers (Laser) 06/2021 - 09/2002
3	Heavy Ion Radiotherapy 01/2021 - 01/2018